PROBISEARCH has participated in the first European congress aimed at finding new alternatives for zinc oxide at high doses. The Zero Zinc Summit 2019 has been held in Copenhagen (Denmark) on June 17 and 18, 2019, with an attendance of 450 people from more than 20 different nationalities.
In 2017, the European Medicines Agency (EMA) dictated a withdrawal period for zinc oxide until the year 2022. This product, widely used for the control of diarrhea at weaning in piglets, is highly polluting for the environment and it has been shown that it selects bacteria with antibiotic resistance genes. Both situations suppose a great impact for Public Health.
In the Summit, alternatives that are in the market, such as probiotics, prebiotics or high digestibility protein, and those expected soon, were explained. However, none is as effective as zinc oxide, so that, after the horizon of 2022, new strategies for the control of diarrhea at weaning will be composed by the combination of several of these alternatives simultaneously.
PROBISEARCH is a leader in probiotics research and has recently submitted a patent application for a new strain with promising results in improving piglet production. PROBISEARCH has assembled a multidisciplinary team with expertise in the development and application of microbiological, immunological, metagenomic, transcriptomic, metabolomic and / or proteomic techniques, who have found scientific evidence on the effectiveness of their strains. Additionally, PROBISEARCH has a track record in the design and development of clinical trials in probiotics in accordance with Good Clinical Practices.